Translational research on trauma, sepsis, and multiple organ damage is continuously evolving,
fostering advancements in the development of diagnostics and therapeutics, and improving
our understanding of the complex pathophysiological mechanisms underlying these life-threatening
conditions. The contributors of this special issue explore the different aspects of
the pathophysiology of trauma and critical illness. With different approaches, these studies
describe novel potential diagnostic markers, innovative therapeutic interventions, and
elucidate the complex mechanisms underlying immune responses and organ damage in
patients with trauma, sepsis and/or multiple organ failure.
Life-threatening organ dysfunction and failure in trauma and critically ill patients stem from a
dysregulated host response to infection and inflammation. Despite advancements in
understanding the key signaling pathways involved, translating this knowledge into organprotective
therapies remains challenging. Current treatments primarily rely on infection
control, antibiotics, supportive care, and early goal-directed therapy.
Trauma and sepsis-induced organ dysfunction are driven by excessive systemic inflammation,
secondary to tissue damage and ischemia-reperfusion injury. The endothelial glycocalyx is a
critical early site involved in triggering a pro-inflammatory response. Alterations in its
structure lead to the release of degradation products and damage-associated molecular
patterns (DAMPs) that, along with pathogen-associated molecular patterns (PAMPs), amplify
systemic inflammation and, hence, contribute to organ dysfunction including acute kidney
injury, respiratory failure, and cardiomyopathy.
Three major fields of research have been covered by the authors. First, in terms of sepsis
diagnosis and treatment, Dennhardt et al. investigate the clinical significance of circulating
cell-free DNA (cfDNA) levels in sepsis patients as predictors of both mortality and sepsisassociated
acute kidney injury, suggesting elevated cfDNA levels as a potential enhancer of
risk assessment in sepsis (1). Similarly, Qiang et al. explore the therapeutic potential of
progesterone in sepsis, presenting promising results in septic mice and patients by inhibiting
procathepsin-L-mediated inflammation (2). Guggemos et al. investigate the impact of specific
polymorphisms of the ATP-sensitive P2X7 receptor on sepsis susceptibility and prognosis,
revealing their potential role as genetic markers (3). Wakeley et al. examine the role of
Herpes virus entry mediator in neonatal sepsis response, highlighting its importance in
vascular and hemodynamic resilience (4), while Kasper et al. study the effects of
hemadsorption therapy on endothelial barrier dysfunction in sepsis in vitro, indicating its
potential transient clinical improvement (5).
Second, with a focus on trauma, injury, and organ damage, Horner et al. explore the immune
suppressive role of DAMPs in sterile traumatic injury, proposing potential therapeutic
strategies to mitigate immune suppression in their review (6). Wolfschmitt et al. investigate
the impact of hyperoxemia on the metabolism of circulating immune cells during intensive
care, focusing on granulocytes in models of acute subdural hematoma and hemorrhagic shock
(7). Groven et al. explore the association between circulating miRNA expression in
extracellular vesicles (EVs) as biomarkers for specific injuries following multiple trauma and
surgical invasiveness (8). Meng et al. investigate how aging influences liver inflammation and
damage after trauma, highlighting dysregulated immune responses (9), while Zhou et al.
examine the exacerbation of lung damage after trauma in aged mice, focusing on the role of
NF-κB and inflammasomes (10). Neu et al. explore the cardiovascular impairment in a
murine model of hemolytic-uremic syndrome induced by Shiga toxin, a model which
replicates the extrarenal manifestations observed in HUS patients (11). Fachet et al. propose a
feature-based risk assessment system for predicting hyperinflammatory patterns and
infectious outcomes in polytrauma patients using predictive machine learning modeling (12).
The third part of this article collection addresses therapeutic interventions and drug
repurposing. Verra et al. investigate the effects of baricitinib, a JAK1/JAK2 inhibitor, on
sepsis-induced cardiac dysfunction and multiple-organ failure, suggesting its potential for
trauma-associated sepsis (13). Hof et al. study the effects of carbachol on gastric and oral
microcirculation during hemorrhagic shock in dogs, highlighting its potential therapeutic use
in improving tissue oxygenation (14). Yamaga et al. discuss potential therapeutic strategies
targeting DAMPs to alleviate radiation-induced injury, focusing on the mechanisms of DAMP
release and their detrimental effects on the immune system (15). To advance our
understanding of critical illness, Li et al. identify key genes and pathways associated with
DNA damage responses, inflammation, and cellular senescence in elderly patients with acute
respiratory distress syndrome, offering insights into potential diagnostic biomarkers and
therapeutic targets (16). Murao et al. utilize single-cell RNA sequencing to investigate
immune cell responses in sepsis, providing insights into distinct immune cell subsets and their
roles in inflammation and tissue repair, thus enhancing our understanding of the
pathophysiology of sepsis (17). Wang et al. conducted the LiBOD study to assess the
potential of serum-derived EVs as biomarkers for decision-making in polytrauma cases,
suggesting specific EVs as valuable biomarkers for assessing and monitoring the severity of
polytrauma and associated organ damage (18).
These studies collectively contribute to a better understanding of diagnostic markers,
therapeutic interventions, immune responses, and the mechanisms underlying organ injury
and dysfunction in trauma, sepsis, and related conditions, offering potential avenues for
improving care and outcomes of patients with critical illness.
As we review the research presented in this issue, it is clear how scientific research
significantly shapes the field of trauma and critical care medicine, addressing the issue of
improving patient outcomes, moving towards precision medicine in intensive care.
We conclude this special issue with deep gratitude to the researchers, clinicians, and patients
whose dedication has made this work possible. We hope the insights from these studies will
be interesting and educational to our readers and help developing this area of research on a
challenging condition.
